BSEBoard Meeting6d ago · 4 Nov 2026, 05:15 pm

Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. To consider and approve the un-Audited Standalone & Consolidated financial results of the Company for the quarter and half-year ending September 30, 2026. 2. Any other item(s) with the permission of the Chairman.

Alpa Laboratories Ltd · 532878

✦ AI SummaryResults

Alpa Laboratories Ltd has scheduled a Board Meeting on 14/11/2026 to consider and approve the un-Audited Standalone & Consolidated financial results for the quarter and half-year ending September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Alpa Laboratories Ltd - 532878 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September, 2026 Along With Limited Review Report Thereon.

Attachments (1)

📄

8e3ff1c1-3fde-4d22-a521-32aa15c19b88.pdf

pdf

Download →
View document text
ALPA Alpa Laboratories Ltd. CIN : L85195MP1988PLC004446 Registered Office : 33/2, Pigdamber A.B. Road - 453 446 Distt., Indore - (M.P) India Phone No. : +91 731-429 4587 Fax No. : +91 730-429 4444 Email : cs@alpalabs.in | Website : www.alpalabs.in Date: - 04" November, 2026 To, To, Listing Department, Listing Department, BSE Limited. National Stock Exchange of India Limited. Rotunda Building, PJ Towers ‘Exchange Plaza’, C-1, Block G, Dalal Street, Fort, Bandra - Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai — 400 051 Scrip Code: 532878 Scrip Code: ALPA Subject: Prior Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that the meeting of the Board ofD irectors of the Company is scheduled to be held on Saturday, the 14" day of November 2026 at 02:00 P.M. inter-alia 1. To consider and approve the un-Audited Standalone & Consolidated financial results of the Company for the quarter and half-year ending September 30, 2026. 2. Any other item(s) with the permission of the Chairman. Further, the Trading Window for dealing in the securities of the Company by the Designated Persons and their immediate relatives has been closed from the 01% day of October, 2026 and iALPA Alpa Laboratories Ltd. CIN : L85195MP1988PLC004446 Registered Office : 33/2, Pigdamber A.B. Road - 453 446 Distt., Indore - (M.P.) india Phone No. : +31 731-429 4567 Fax No. : +91 730-429 4444 Email : cs@alpalabs.in | Website : www.alpalabs.in will continue to remain closed till completion of 48 hours afier the declaration of Unaudited Financial Results of the Company for the Half-year ended on 30" September, 2026 as required under the SEBI (Prohibition of Insider Trading) Regulation, 2015 as amended. We request you to please take on record the above said information for your reference and record. Thanking you, Yours faithfully, For, Alpa Laboratories Limited Diksha Jaswani Company Secretary & Compliance Officer M No. A80495